Figure 1.

Cumulative percentage of subjects with firsttreatment success, defined as the first incidence of blood pressure <130/80 mm Hg, in patients with diabetes and hypertension in the Study of Hypertension and the Efficacy of Lotrel in Diabetes (SHIELD) study, n=cumulative number of subjects with firsttreatment success; *12.5 mg hydrochlorothiazide was added at Week 8 if target blood pressure was not reached; amlodipine besylate/benazepril HCl subjects given hydrochlorothiazide were excluded from data analysis ¹²